Literature DB >> 22563188

Stem cell differentiation and human liver disease.

Wen-Li Zhou1, Claire N Medine, Liang Zhu, David C Hay.   

Abstract

Human stem cells are scalable cell populations capable of cellular differentiation. This makes them a very attractive in vitro cellular resource and in theory provides unlimited amounts of primary cells. Such an approach has the potential to improve our understanding of human biology and treating disease. In the future it may be possible to deploy novel stem cell-based approaches to treat human liver diseases. In recent years, efficient hepatic differentiation from human stem cells has been achieved by several research groups including our own. In this review we provide an overview of the field and discuss the future potential and limitations of stem cell technology.

Entities:  

Keywords:  Bio-artificial liver; Differentiation; Hepatocyte-like cells; Liver development; Pluripotent stem cells; Polymer chemistry; Regenerative medicine; Transplantation

Mesh:

Year:  2012        PMID: 22563188      PMCID: PMC3342599          DOI: 10.3748/wjg.v18.i17.2018

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  73 in total

1.  Future of bioartificial liver support.

Authors:  Robert Afm Chamuleau
Journal:  World J Gastrointest Surg       Date:  2009-11-30

Review 2.  Embryonic development of the liver.

Authors:  Roong Zhao; Stephen A Duncan
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

3.  Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix.

Authors:  E G Schuetz; D Li; C J Omiecinski; U Muller-Eberhard; H K Kleinman; B Elswick; P S Guzelian
Journal:  J Cell Physiol       Date:  1988-03       Impact factor: 6.384

4.  Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.

Authors:  Liang Peng; Dong-ying Xie; Bing-Liang Lin; Jing Liu; Hai-peng Zhu; Chan Xie; Yu-bao Zheng; Zhi-liang Gao
Journal:  Hepatology       Date:  2011-07-14       Impact factor: 17.425

5.  The bone marrow functionally contributes to liver fibrosis.

Authors:  Francesco P Russo; Malcolm R Alison; Brian W Bigger; Eunice Amofah; Aikaterini Florou; Farhana Amin; George Bou-Gharios; Rosemary Jeffery; John P Iredale; Stuart J Forbes
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

Review 6.  Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?

Authors:  José M Miró; Montserrat Laguno; Asuncion Moreno; Antonio Rimola
Journal:  J Hepatol       Date:  2005-11-28       Impact factor: 25.083

7.  Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.

Authors:  Arefeh Ghodsizadeh; Adeleh Taei; Mehdi Totonchi; Ali Seifinejad; Hamid Gourabi; Behshad Pournasr; Nasser Aghdami; Reza Malekzadeh; Navid Almadani; Ghasem Hosseini Salekdeh; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

8.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

9.  Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo.

Authors:  Yuyou Duan; Andreea Catana; Ying Meng; Naoki Yamamoto; Songqing He; Sanjeev Gupta; Sanjiv Sam Gambhir; Mark A Zern
Journal:  Stem Cells       Date:  2007-09-20       Impact factor: 6.277

10.  Identification of bipotential progenitor cells in human liver development.

Authors:  Y Haruna; K Saito; S Spaulding; M A Nalesnik; M A Gerber
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  5 in total

1.  Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection.

Authors:  Gokhan Adas; Bora Koc; Mine Adas; Gokhan Duruksu; Cansu Subasi; Ozgur Kemik; Ahu Kemik; Damlanur Sakiz; Mustafa Kalayci; Sevim Purisa; Seda Unal; Erdal Karaoz
Journal:  Langenbecks Arch Surg       Date:  2016-04-19       Impact factor: 3.445

2.  Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells.

Authors:  Ding Sun; Lei Qin; Yang Xu; Jian-Xia Liu; Li-Ping Tian; Hai-Xin Qian
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 3.  Methods of Liver Stem Cell Therapy in Rodents as Models of Human Liver Regeneration in Hepatic Failure.

Authors:  Nasser Hashemi Goradel; Masoud Darabi; Karim Shamsasenjan; Mostafa Ejtehadifar; Sarah Zahedi
Journal:  Adv Pharm Bull       Date:  2015-09-19

4.  Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells.

Authors:  Ya-Bin Yu; Yan Song; Ya Chen; Feng Zhang; Fu-Zhen Qi
Journal:  Mol Med Rep       Date:  2018-06-18       Impact factor: 2.952

Review 5.  Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential.

Authors:  Pinyan Liu; Yongcui Mao; Ye Xie; Jiayun Wei; Jia Yao
Journal:  Stem Cell Res Ther       Date:  2022-07-26       Impact factor: 8.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.